Dr. Louis Puneky has contributed to 3 publications.
Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
Ejaeidi AA, Craft BS, Puneky LV, Lewis RE, Cruse JM; Exp. Mol. Pathol.. 2015-08-01.
A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecolog...
Dr. Louis Puneky has contributed to 3 publications.
Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
Ejaeidi AA, Craft BS, Puneky LV, Lewis RE, Cruse JM; Exp. Mol. Pathol.. 2015-08-01.
A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecolog...